JP2011528718A5 - - Google Patents

Download PDF

Info

Publication number
JP2011528718A5
JP2011528718A5 JP2011520127A JP2011520127A JP2011528718A5 JP 2011528718 A5 JP2011528718 A5 JP 2011528718A5 JP 2011520127 A JP2011520127 A JP 2011520127A JP 2011520127 A JP2011520127 A JP 2011520127A JP 2011528718 A5 JP2011528718 A5 JP 2011528718A5
Authority
JP
Japan
Prior art keywords
pharmaceutical formulation
condition
disease
pain
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011520127A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011528718A (ja
JP5727374B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/051200 external-priority patent/WO2010011619A1/en
Publication of JP2011528718A publication Critical patent/JP2011528718A/ja
Publication of JP2011528718A5 publication Critical patent/JP2011528718A5/ja
Application granted granted Critical
Publication of JP5727374B2 publication Critical patent/JP5727374B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011520127A 2008-07-21 2009-07-21 大型置換基を有する非フェノール性アミンオピオイド Active JP5727374B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8225508P 2008-07-21 2008-07-21
US61/082,255 2008-07-21
PCT/US2009/051200 WO2010011619A1 (en) 2008-07-21 2009-07-21 Large substituent, non-phenolic amine opioids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014204620A Division JP2015044819A (ja) 2008-07-21 2014-10-03 大型置換基を有する非フェノール性アミンオピオイド

Publications (3)

Publication Number Publication Date
JP2011528718A JP2011528718A (ja) 2011-11-24
JP2011528718A5 true JP2011528718A5 (https=) 2012-01-12
JP5727374B2 JP5727374B2 (ja) 2015-06-03

Family

ID=41137538

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011520127A Active JP5727374B2 (ja) 2008-07-21 2009-07-21 大型置換基を有する非フェノール性アミンオピオイド
JP2014204620A Pending JP2015044819A (ja) 2008-07-21 2014-10-03 大型置換基を有する非フェノール性アミンオピオイド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014204620A Pending JP2015044819A (ja) 2008-07-21 2014-10-03 大型置換基を有する非フェノール性アミンオピオイド

Country Status (7)

Country Link
US (1) US20100190817A1 (https=)
EP (1) EP2318372B9 (https=)
JP (2) JP5727374B2 (https=)
AU (1) AU2009274147B2 (https=)
CA (1) CA2731429C (https=)
ES (1) ES2534055T3 (https=)
WO (1) WO2010011619A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2731429C (en) * 2008-07-21 2016-12-13 Mark P. Wentland Large substituent, non-phenolic amine opioids
US9119848B2 (en) 2009-12-04 2015-09-01 Alkermes Pharma Ireland Limited Morphinan derivatives for the treatment of drug overdose
AU2011232628B2 (en) * 2010-03-22 2015-04-09 Rensselaer Polytechnic Institute Morphinane derivatives containing a carboxamide group as opioid receptor ligands
HUE065427T2 (hu) 2010-08-23 2024-05-28 Alkermes Pharma Ireland Ltd Eljárások antipszichotikum által indukált súlygyarapodás kezelésére
SMT201700400T1 (it) 2011-06-29 2017-09-07 Alkermes Inc Composti oppioidi ad azione periferica
US9211293B2 (en) 2011-12-15 2015-12-15 Alkermes Pharma Ireland Limited Opioid agonist antagonist combinations
EP3003311A2 (en) 2013-05-24 2016-04-13 Alkermes Pharma Ireland Limited Methods for treating depressive symptoms
CA2911231C (en) 2013-05-24 2021-12-07 Alkermes Pharma Ireland Limited Morphan and morphinan analogues, and methods of use
WO2022101444A1 (en) 2020-11-12 2022-05-19 Alkermes Pharma Ireland Limited Immediate release multilayer tablet

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4340437B2 (ja) * 2000-10-31 2009-10-07 レンセラール ポリテクニック インスティチュート ８−カルボキサミド−２，６−メタノ−３−ベンズアゾシン
AU2003281060A1 (en) * 2002-07-16 2004-02-02 Rensselaer Polytechnic Institute Process for conversion of phenols to carboxamides via the succinimide esters
WO2007014137A2 (en) * 2005-07-21 2007-02-01 Rensselaer Polytechnic Institute 8-carboxamido-substituted-2 , 6-methano-3-benzazocines and 3 - carboxamido- substituted morphanes as opioid receptor binding agents
CA2731429C (en) * 2008-07-21 2016-12-13 Mark P. Wentland Large substituent, non-phenolic amine opioids

Similar Documents

Publication Publication Date Title
JP2011528718A5 (https=)
JP2010535814A5 (https=)
CL2008001215A1 (es) Compuestos derivados de heterociclos nitrogenados condensados; composicion farmaceutica; procedimiento para preparar la composicion farmaceutica; y uso en el tratamiento de enfermedades tales como diabetes, dislipidemia, obesidad y alzheimer.
WO2007122581A3 (en) Compositions and kits of phenylephrine
RU2582676C3 (ru) Некоторые химические соединения, композиции и способы
WO2008021851A3 (en) Novel compounds as antagonists or inverse agonists for opioid receptors
NZ592723A (en) Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
WO2011094337A8 (en) Glucagon antagonist - gip agonist conjugates and compositions for the treatment of metabolic disorders and obesity
CL2008001125A1 (es) Compuestos derivados de pirimidinona condensada con heterociclos; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como diabetes, sindrome metabolico y obesidad.
CL2008001126A1 (es) Compuestos derivados de pirimidinona condensada con heterociclos; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como diabetes, sindrome metabolico y obesidad.
PH12013502674A1 (en) Compounds for the treatment of addiction
UA86595C2 (ru) Гамма-кристаллическая форма гидрохлорида ивабрадина, способ ее получения и фармацевтическая композиция, которая ее содержит
CL2007003765A1 (es) Compuestos derivados de 2-oxo-4-hidroxi-benzotiazol; procesode preparacion; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de enfermedades tales como epoc, bronquitis, asma y bronquiectasias.
EA200870449A1 (ru) Лечение воспалительных и язвенных заболеваний кишечника опиоидными антагонистами
Shaw et al. Originals and Papers
CL2007002958A1 (es) Compuestos derivados de heteroaril-carboxamida, antagonistas del receptor de quimioquina; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades tales como rechazo de transplante de organos, artritis reumatoidea, lupus, entr
EP2257543A4 (en) MUSCARINIC RECEPTOR AGONISTS, COMPOSITIONS, PROCESSING METHODS AND PREPARATION METHODS THEREOF
WO2007090113A3 (en) Use of antifungal compositions to treat upper gastrointestinal conditions
MX2009008363A (es) Combinacion de un antagonista de receptor muscarinico y un agonista de receptor adrenergico beta 2.
JP2010508310A5 (https=)
CL2007003590A1 (es) Compuestos derivados de aril sulfamida; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en prevencion y tratamiento de sintomas vasomotrices, disfuncion sexual, transtornos gastrointestinales, transt
CL2008001563A1 (es) Compuestos derivados de benzodioxanos condensados con heterociclos; metodo de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como depresion, ansiedad, crisis de panico, entre otras.
WO2011045760A3 (en) Micronized olmesartan medoxomil compositions
EP1937223A4 (en) PELLET FORMULATION OF AN ALPHA1 RECEPTOR ANTAGONIST WITH DELAYED RELEASE AND METHOD OF MANUFACTURING THEREOF
SI1642897T1 (sl) Alfa kristalna oblika stroncijevega ranelata, postopek za njeno pripravo in farmacevtski sestavki, ki jo vsebujejo